[go: up one dir, main page]

AR002069A1 - Soluciones estables, concentradas y localmente compatibles de eritromicilamina. - Google Patents

Soluciones estables, concentradas y localmente compatibles de eritromicilamina.

Info

Publication number
AR002069A1
AR002069A1 ARP960102657A AR10265796A AR002069A1 AR 002069 A1 AR002069 A1 AR 002069A1 AR P960102657 A ARP960102657 A AR P960102657A AR 10265796 A AR10265796 A AR 10265796A AR 002069 A1 AR002069 A1 AR 002069A1
Authority
AR
Argentina
Prior art keywords
stable
solutions
erythromicilamine
concentrated
erythromycylamine
Prior art date
Application number
ARP960102657A
Other languages
English (en)
Spanish (es)
Inventor
Stefan Dr Leiner
Werner Dr Schleicher
Original Assignee
Boehringer Ingelheim Vetmed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmed filed Critical Boehringer Ingelheim Vetmed
Publication of AR002069A1 publication Critical patent/AR002069A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ARP960102657A 1995-05-23 1996-05-22 Soluciones estables, concentradas y localmente compatibles de eritromicilamina. AR002069A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19518917A DE19518917A1 (de) 1995-05-23 1995-05-23 Stabile, konzentrierte lokalverträgliche Erythromycylamin-Lösungen

Publications (1)

Publication Number Publication Date
AR002069A1 true AR002069A1 (es) 1998-01-07

Family

ID=7762671

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960102657A AR002069A1 (es) 1995-05-23 1996-05-22 Soluciones estables, concentradas y localmente compatibles de eritromicilamina.

Country Status (6)

Country Link
AR (1) AR002069A1 (de)
AU (1) AU5898296A (de)
DE (1) DE19518917A1 (de)
IL (1) IL118381A0 (de)
WO (1) WO1996037190A1 (de)
ZA (1) ZA964082B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5723447A (en) * 1996-07-02 1998-03-03 Rhone Merieux, Inc. Water miscible erythromycin solutions
NZ523693A (en) * 2000-07-10 2004-08-27 Chiron Corp Macrolide formulations for inhalation and methods of treatment of endobronchial infections

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA695765B (en) * 1968-08-29 1971-03-31 Lilly Co Eli Erythromycylamine and process for preparing same
ZA71763B (en) * 1970-04-13 1972-03-29 Lilly Industries Ltd Erythromycylamines via hydrazones
ZA87591B (en) * 1986-02-03 1988-09-28 Lilly Co Eli Novel derivatives of eryhromycylamine
US5110800A (en) * 1986-02-18 1992-05-05 Eli Lilly And Company Derivatives of erythromycylamine
DE4410637C1 (de) * 1994-03-26 1995-09-21 Boehringer Ingelheim Vetmed Injizierbare Lösungen von Dirithromycin

Also Published As

Publication number Publication date
ZA964082B (en) 1996-11-22
IL118381A0 (en) 1996-09-12
DE19518917A1 (de) 1996-11-28
AU5898296A (en) 1996-12-11
WO1996037190A1 (de) 1996-11-28

Similar Documents

Publication Publication Date Title
MX9401396A (es) Dispositivos distribuidores eclosionables osmoticos activados por el ph.
ES2077554T1 (es) Formulaciones inyectables acuosas utiles para un radiodiagnostico que comprenden compuestos aromaticos yodados usados como medio de contraste en rayos x.
BG102708A (en) 4-aminopyrimidine derivatives, medicamentous preparations containing them, their application and method for their preparation
BG98902A (bg) Имидазолови производни и тяхната употреба като инхибитори на цитокин
DE3869872D1 (de) Lyophilisierte pharmazeutische zubereitung eines neocarzinostatinderivates.
DK0633721T3 (da) Rensning af blodplader med 8-metoxypsoralen
BR9702362A (pt) Novas fomrulações lìquidas estáveis à base de paracetamol e seu modo de preparação.
EP1025846A4 (de) Wässerige flüssige zubereitungen
ES2108592T3 (es) Composicion espesada en medio acuoso y procedimiento de espesamiento de un medio acuoso.
BR0014820A (pt) Solução de diálise incluindo agente osmótico de poliglicol, e seu uso
IT1303671B1 (it) Sali dell'acido nitrico con farmaci attivi nel trattamento dipatologie del sistema respiratorio
ES8801580A1 (es) Un procedimiento para producir una solucion de glicosido de antraciclina exenta de pirogenos, esteril
BR9506840A (pt) Preparação farmacêutica contendo ativadores de plasminogênio
ES2079327A1 (es) Formulaciones farmaceuticas de cefaclor.
AR002069A1 (es) Soluciones estables, concentradas y localmente compatibles de eritromicilamina.
EP0200157A3 (en) Use of an aqueous stabilized chlorite matrix solution in infectious conditions
ATE61522T1 (de) Pharmazeutische zubereitung zur behandlung von tinea pedis.
HUP0302310A2 (hu) Alfa-(2,4-diszulfo-fenil)-N-terc-butil-nitron új gyógyszerformái és eljárás az előállításukra
BR9611588A (pt) Utilização da flupirtina na profilaxia e terapia de doenças associadoas com danos ao sistema celular hematopoiético
RU2003122531A (ru) Способ культивирования азотофиксирующих бактерий
NO902607L (no) Krystallinske cefem-syreaddisjonssalter og fremgangsmaate for fremstilling derav.
ES2091764T3 (es) Sistema de purificacion de agua.
ES2122962T3 (es) Derivados de alquileno-dioxibenceno opticamente activos y su uso en terapia.
ES2060057T3 (es) Soluciones acuosas conteniendo proteina.
NO971604L (no) Orale sabeluzolsuspensjoner

Legal Events

Date Code Title Description
FA Abandonment or withdrawal